Vitamin D supplementation protects against reductions in plasma 25-hydroxyvitamin D induced by open-heart surgery: Assess-d trial.


Journal

Physiological reports
ISSN: 2051-817X
Titre abrégé: Physiol Rep
Pays: United States
ID NLM: 101607800

Informations de publication

Date de publication:
02 2021
Historique:
received: 24 11 2020
revised: 14 01 2021
accepted: 15 01 2021
entrez: 13 2 2021
pubmed: 14 2 2021
medline: 15 12 2021
Statut: ppublish

Résumé

Low vitamin D (serum or plasma 25-hydroxyvitamin D (25(OH)D)) is a global pandemic and associates with a greater prevalence in all-cause and cardiovascular mortality and morbidity. Open-heart surgery is a form of acute stress that decreases circulating 25(OH)D concentrations and exacerbates the preponderance of low vitamin D in a patient population already characterized by low levels. Although supplemental vitamin D increases 25(OH)D, it is unknown if supplemental vitamin D can overcome the decreases in circulating 25(OH)D induced by open-heart surgery. We sought to identify if supplemental vitamin D protects against the acute decrease in plasma 25(OH)D propagated by open-heart surgery during perioperative care. Participants undergoing open-heart surgery were randomly assigned (double-blind) to one of two groups: (a) vitamin D (n = 75; cholecalciferol, 50,000 IU/dose) or (b) placebo (n = 75). Participants received supplements on three separate occasions: orally the evening before surgery and either orally or per nasogastric tube on postoperative days 1 and 2. Plasma 25(OH)D concentrations were measured at baseline (the day before surgery and before the first supplement bolus), after surgery on postoperative days 1, 2, 3, and 4, at hospital discharge (5-8 days after surgery), and at an elective outpatient follow-up visit at 6 months. Supplemental vitamin D abolished the acute decrease in 25(OH)D induced by open-heart surgery during postoperative care. Moreover, plasma 25(OH)D gradually increased from baseline to day 3 and remained significantly increased thereafter but plateaued to discharge with supplemental vitamin D. We conclude that perioperative vitamin D supplementation protects against the immediate decrease in plasma 25(OH)D induced by open-heart surgery. ClinicalTrials.gov Identifier: NCT02460211.

Identifiants

pubmed: 33580636
doi: 10.14814/phy2.14747
pmc: PMC7881347
doi:

Substances chimiques

Biomarkers 0
Vitamin D 1406-16-2
Cholecalciferol 1C6V77QF41
25-hydroxyvitamin D A288AR3C9H

Banques de données

ClinicalTrials.gov
['NCT02460211']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14747

Informations de copyright

© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.

Références

Eur J Cardiothorac Surg. 2000 Jun;17(6):737-42
pubmed: 10856869
Am J Clin Nutr. 2008 Jun;87(6):1738-42
pubmed: 18541563
J Clin Endocrinol Metab. 2012 Apr;97(4):1153-8
pubmed: 22442274
Am J Clin Nutr. 1998 Oct;68(4):854-8
pubmed: 9771862
Ann Clin Biochem. 2012 Jul;49(Pt 4):399-401
pubmed: 22543926
Sci Rep. 2019 Oct 15;9(1):14784
pubmed: 31616013
J Clin Pathol. 2013 Jul;66(7):620-2
pubmed: 23454726
J Clin Endocrinol Metab. 2014 Apr;99(4):1461-9
pubmed: 24423347
Crit Care Med. 1998 Feb;26(2):285-9
pubmed: 9468166
Age (Dordr). 2014;36(4):9694
pubmed: 25086618
J Clin Endocrinol Metab. 2015 Jan;100(1):72-80
pubmed: 25365313
Med Hypotheses. 2014 Feb;82(2):134-7
pubmed: 24332533
Diagnostics (Basel). 2020 May 04;10(5):
pubmed: 32375318
J Clin Endocrinol Metab. 2004 Nov;89(11):5387-91
pubmed: 15531486
J Clin Endocrinol Metab. 2013 Jul;98(7):3001-9
pubmed: 23666975
Crit Care Med. 1992 Jul;20(7):934-41
pubmed: 1617986
Free Radic Biol Med. 2019 Feb 1;131:376-381
pubmed: 30578920
PLoS One. 2014 Mar 25;9(3):e92614
pubmed: 24667823
Crit Care Med. 2012 Jul;40(7):2073-81
pubmed: 22584760
Crit Care. 2010;14(6):R216
pubmed: 21110839
Metabolism. 2021 Feb;115:154434
pubmed: 33217408
Am J Clin Nutr. 2011 May;93(5):1006-11
pubmed: 21411617
Eur Heart J. 2013 May;34(18):1358-64
pubmed: 23315905
Am J Clin Nutr. 2008 Mar;87(3):688-91
pubmed: 18326608
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):204-5
pubmed: 17234402
Antioxid Redox Signal. 2018 Dec 10;29(17):1792-1807
pubmed: 30160165
Am J Clin Nutr. 2012 Jan;95(1):64-71
pubmed: 22158726
J Int Med Res. 2008 Sep-Oct;36(5):1070-6
pubmed: 18831903
Cytokine. 2015 Feb;71(2):132-8
pubmed: 25461390
Nutr Metab (Lond). 2013 Dec 06;10(1):69
pubmed: 24313936
Endocr Res. 2011;36(4):135-41
pubmed: 21973232
N Engl J Med. 2007 Jul 19;357(3):266-81
pubmed: 17634462
J Cell Physiol. 1990 Mar;142(3):652-6
pubmed: 1690216
Osteoporos Int. 2017 Mar;28(3):1013-1020
pubmed: 27826645
J Bone Miner Res. 2006 Jan;21(1):37-47
pubmed: 16355272
Inflamm Res. 2002 Dec;51(12):579-86
pubmed: 12558191
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:91-5
pubmed: 24120915
Arch Intern Med. 2008 Jun 23;168(12):1340-9
pubmed: 18574092
Biochem Biophys Res Commun. 1985 Mar 15;127(2):596-603
pubmed: 3919734
Clin Nutr. 2019 Dec;38(6):2756-2762
pubmed: 30583965
Ann Thorac Surg. 2006 Dec;82(6):2179-86
pubmed: 17126131
Am J Cardiol. 2010 Oct 1;106(7):963-8
pubmed: 20854958
J Clin Endocrinol Metab. 1987 Dec;65(6):1201-9
pubmed: 3119653
J Nutr Sci. 2016 Feb 15;5:e10
pubmed: 27066255
PLoS One. 2018 Dec 12;13(12):e0208806
pubmed: 30540842
Sci Rep. 2016 Nov 07;6:36519
pubmed: 27819306
Antioxid Redox Signal. 2015 Sep 10;23(8):688-93
pubmed: 25816831
Cytokine. 2012 Oct;60(1):23-6
pubmed: 22704696
Trans R Soc Trop Med Hyg. 2006 Jan;100(1):41-4
pubmed: 16171835
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):567-71
pubmed: 17267208
Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22593-8
pubmed: 21149724
Heart Lung Circ. 2014 Oct;23(10):978-80
pubmed: 24996389

Auteurs

Tyler Barker (T)

Precision Genomics, Intermountain Healthcare, St. George, Utah, USA.
Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.

Heidi T May (HT)

Heart Institute, Intermountain Healthcare, Salt Lake City, Utah, USA.

John R Doty (JR)

Heart Institute, Intermountain Healthcare, Salt Lake City, Utah, USA.
School of Medicine, University of Utah, Salt Lake City, Utah, USA.

Donald L Lappe (DL)

Heart Institute, Intermountain Healthcare, Salt Lake City, Utah, USA.
School of Medicine, University of Utah, Salt Lake City, Utah, USA.

Kirk U Knowlton (KU)

Heart Institute, Intermountain Healthcare, Salt Lake City, Utah, USA.
School of Medicine, University of Utah, Salt Lake City, Utah, USA.

John Carlquist (J)

Heart Institute, Intermountain Healthcare, Salt Lake City, Utah, USA.

Kristin Konery (K)

Heart Institute, Intermountain Healthcare, Salt Lake City, Utah, USA.

Shannon Inglet (S)

Heart Institute, Intermountain Healthcare, Salt Lake City, Utah, USA.

Ben Chisum (B)

Heart Institute, Intermountain Healthcare, Salt Lake City, Utah, USA.

Oxana Galenko (O)

Heart Institute, Intermountain Healthcare, Salt Lake City, Utah, USA.

Jeffrey L Anderson (JL)

Heart Institute, Intermountain Healthcare, Salt Lake City, Utah, USA.
School of Medicine, University of Utah, Salt Lake City, Utah, USA.

Joseph B Muhlestein (JB)

Heart Institute, Intermountain Healthcare, Salt Lake City, Utah, USA.
School of Medicine, University of Utah, Salt Lake City, Utah, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH